Luo X, Du X, Lv X, Yang Y, Zhang X, Huang L
JAMA Netw Open. 2024; 7(10):e2439080.
PMID: 39412805
PMC: 11581593.
DOI: 10.1001/jamanetworkopen.2024.39080.
Niazi S
Pharmaceutics. 2024; 16(7).
PMID: 39065616
PMC: 11279857.
DOI: 10.3390/pharmaceutics16070918.
Avery J, Bell J, Baryolay K, Rodin G, Nissim R, Balneaves L
BMC Cancer. 2024; 24(1):373.
PMID: 38528488
PMC: 10962144.
DOI: 10.1186/s12885-024-12119-7.
Cambrosio A, Campbell J, Drilon A, Keating P, Polk J
Sociol Health Illn. 2023; 46(3):495-513.
PMID: 37796533
PMC: 11878200.
DOI: 10.1111/1467-9566.13719.
Panzer A, Ingham M, Martin S, Chambers J
J Manag Care Spec Pharm. 2023; 29(5):464-471.
PMID: 36989444
PMC: 10394180.
DOI: 10.18553/jmcp.2023.22415.
Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation.
Herink M, Johnston K, Breninger K, Wu E, Irwin A
Pharmacy (Basel). 2022; 10(5).
PMID: 36287447
PMC: 9610476.
DOI: 10.3390/pharmacy10050126.
Feasibility of Randomized Controlled Trials for Cancer Drugs Approved by the Food and Drug Administration Based on Single-Arm Studies.
Rittberg R, Czaykowski P, Niraula S
JNCI Cancer Spectr. 2021; 5(4).
PMID: 34409254
PMC: 8364671.
DOI: 10.1093/jncics/pkab061.
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.
Von Hoff D, Clark G, Coltman C, Disis M, Eckhardt S, Ellis L
Clin Cancer Res. 2021; 27(20):5472-5481.
PMID: 34312215
PMC: 8530870.
DOI: 10.1158/1078-0432.CCR-21-1799.
Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring.
El Missiri A, Rayan M, Awad M, El Desoky A
Egypt Heart J. 2020; 72(1):37.
PMID: 32613565
PMC: 7329943.
DOI: 10.1186/s43044-020-00070-4.
Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences.
Simons E, Smith D, Gao D, Camidge D
J Thorac Oncol. 2020; 15(9):1425-1433.
PMID: 32353598
PMC: 7667578.
DOI: 10.1016/j.jtho.2020.04.020.
Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection.
Ibrahim M, Sharafeldin A, Mousa N, Mousa T, El Missiri A
Egypt Heart J. 2020; 72(1):7.
PMID: 32030482
PMC: 7005241.
DOI: 10.1186/s43044-020-0042-y.
US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis.
Razavi M, Glasziou P, Klocksieben F, Ioannidis J, Chalmers I, Djulbegovic B
JAMA Netw Open. 2019; 2(9):e1911111.
PMID: 31509209
PMC: 6739727.
DOI: 10.1001/jamanetworkopen.2019.11111.
Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan.
Nagai S
Int J Mol Sci. 2019; 20(15).
PMID: 31382625
PMC: 6696404.
DOI: 10.3390/ijms20153801.
Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF -mutant melanoma.
Harris A, Lee S, Dawson L, Marlow L, Edenfield B, Durham W
Oncotarget. 2018; 9(13):10905-10919.
PMID: 29541385
PMC: 5834273.
DOI: 10.18632/oncotarget.23649.
Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System.
Biomy R, Abdelshafy M, Abdelmonem A, Abu-Elenin H, Ghaly G
Clin Med Insights Cardiol. 2017; 11:1179546817713204.
PMID: 28804248
PMC: 5484549.
DOI: 10.1177/1179546817713204.
Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies.
Blumenthal G, Kluetz P, Schneider J, Goldberg K, McKee A, Pazdur R
Oncologist. 2017; 22(7):762-767.
PMID: 28576856
PMC: 5507655.
DOI: 10.1634/theoncologist.2017-0152.
Warning About Shortcuts in Drug Development.
Califf R
J Am Heart Assoc. 2017; 6(3).
PMID: 28325714
PMC: 5524047.
DOI: 10.1161/JAHA.117.005737.
Managing Expectations in the Transition to Proof of Concept Studies.
Kieber-Emmons T, Makhoul I, Pennisi A, Siegel E, Emanuel P, Monzavi-Karbassi B
Rev Recent Clin Trials. 2017; 12(2):111-123.
PMID: 28325150
PMC: 9252264.
DOI: 10.2174/1574887112666170321121250.
Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.
Sullivan H, ODonoghue A, Rupert D, Willoughby J, Amoozegar J, Aikin K
J Health Commun. 2016; 21(11):1198-1207.
PMID: 27805473
PMC: 7325647.
DOI: 10.1080/10810730.2016.1237594.
Regulatory approval pathways for anticancer drugs in Japan, the EU and the US.
Nagai S, Ozawa K
Int J Hematol. 2016; 104(1):73-84.
PMID: 27084259
DOI: 10.1007/s12185-016-2001-7.
